☆ 4.7 Article

Androgen-Responsive Oncogenic lncRNA RP11-1023L17.1 Enhances c-Myc Protein Stability in Prostate Cancer

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Related references

Note: Only part of the references are listed.

Article Oncology

FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer

Ning Zhang et al.

Summary: Our study demonstrates that elevated expression of PHPT1 is associated with poor overall survival in lung cancer patients, particularly in those carrying EGFR mutations. PHPT1 plays a critical role in promoting the proliferation, clonogenicity, and growth of EGFR mutant lung cancer cells by activating the ERK/MAPK pathway. In addition, we identify FBXO32 as an E3 ubiquitin ligase for PHPT1, and its knockdown leads to PHPT1 accumulation and activation of the ERK/MAPK pathway, promoting lung cancer cell growth. These findings suggest that PHPT1 may serve as a potential biomarker and therapeutic target for acquired erlotinib resistance in lung cancer patients.

CELLULAR ONCOLOGY (2022)

Add to Collection

Review Oncology

MYC as a target for cancer treatment

Michael J. Duffy et al.

Summary: The MYC gene, with its three paralogs, is a common driver gene in cancer, making it an attractive target for cancer treatment. While traditionally considered undruggable, recent advancements have shown potential compounds that can inhibit MYC and exhibit anticancer activity.

CANCER TREATMENT REVIEWS (2021)

Add to Collection

Article Cell Biology

Down-regulated LINC00115 inhibits prostate cancer cell proliferation and invasion via targeting miR-212-5p/FZD5/Wnt/beta-catenin axis

Naixiong Peng et al.

Summary: LINC00115 is significantly up-regulated in prostate cancer tissues and inhibits cell proliferation and invasion by targeting the miR-212-5p/FZD5/Wnt/β-catenin axis. This suggests that LINC00115 may be a potential therapeutic target for prostate cancer patients.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Cell Biology

LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1/S transition and cell proliferation

Jin-Yu Liu et al.

Summary: The study reveals that SNHG17 interacts with LRPPRC to enhance c-Myc expression, accelerate G1/S transition and cell proliferation, promoting tumor growth. High levels of SNHG17 or LRPPRC are associated with lower survival rates in HCC patients.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Cell Biology

Exosomal long noncoding RNA HOXD-AS1 promotes prostate cancer metastasis via miR-361-5p/FOXM1 axis

Yongming Jiang et al.

Summary: Exosomal lncRNA HOXD-AS1 is upregulated in CRPC and metastatic PCa, promoting cancer cell metastasis by modulating the miR-361-5p/FOXM1 axis. Serum exosomal HOXD-AS1 is correlated with disease characteristics and survival outcomes, serving as a potential liquid biopsy biomarker for metastatic PCa detection and treatment guidance.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Medicine, General & Internal

Prostate cancer

Richard J. Rebello et al.

Summary: Prostate cancer is a prevalent disease among men, with key genetic alterations including gene fusions, oncogene amplification, and mutations in androgen receptors. Treatment options range from active surveillance to surgery and radiotherapy for localized disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Add to Collection

Article Oncology

p38 MAPK Inhibition Mitigates Hypoxia-Induced AR Signaling in Castration-Resistant Prostate Cancer

Serina Cheung et al.

Summary: Targeting the p38 MAPK protein kinase can inhibit growth and survival of castration-resistant prostate cancer cells, regardless of oxygen levels, and may prolong the survival of tumor-bearing mice. This demonstrates the potential of p38 MAPK inhibition as a therapeutic strategy for disrupting AR signaling in the heterogeneous CRPC tumor microenvironment.

CANCERS (2021)

Add to Collection

Article Oncology

LINC00494 Promotes Ovarian Cancer Development and Progression by Modulating NFκB1 and FBXO32

Yang Shu et al.

Summary: The study identified LINC00494 as a novel oncogenic lncRNA in ovarian cancer, which promotes cancer progression by modulating FBXO32 through binding with NF kappa B1. This provides new insights into the pathogenesis of ovarian cancer and suggests potential therapeutic targets.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Long non-coding RNA regulating androgen receptor signaling in breast and prostate cancer

Shashank Kumar et al.

Summary: lncRNAs are a group of non-coding RNAs consisting of more than 200 nucleotides of RNA transcripts that play important role in tumor development. Recent studies have shown aberrant expression of several lncRNAs linked with various human cancers, with potential prognostic and therapeutic implications.

CANCER LETTERS (2021)

Add to Collection

Review Oncology

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies

Aasems Jacob et al.

Summary: Prostate cancer growth is primarily mediated by androgen signaling pathways, but resistance mechanisms are complex. Treatment strategies focus on inhibiting androgen signaling through various pathways, yet disease progression eventually occurs in patients. Multiple clinical trials are exploring therapeutic strategies to overcome these resistance mechanisms.

CANCERS (2021)

Add to Collection

Article Cell Biology

Long Non-coding RNAs LINC01679 as a Competitive Endogenous RNAs Inhibits the Development and Progression of Prostate Cancer via Regulating the miR-3150a-3p/SLC17A9 Axis

Yuan-yuan Mi et al.

Summary: This study focused on selecting potential lncRNA signatures related to prostate cancer for prognosis prediction accuracy. Through bioinformatics analysis, it was revealed that LINC01679 regulates the miR-3150a-3p/SLC17A9 axis, playing a crucial role in suppressing PCa development.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Biology

AC016745.3 Regulates the Transcription of AR Target Genes by Antagonizing NONO

Yali Lu et al.

Summary: The study elucidated the role of lncRNA AC016745.3 in prostate cancer, showing its ability to inhibit the pro-oncogenic functions of NONO by binding to it, thereby affecting the proliferation and migration of tumor cells.

LIFE-BASEL (2021)

Add to Collection

Review Cell Biology

Androgen Receptor-Related Non-coding RNAs in Prostate Cancer

Yongyong Yang et al.

Summary: Prostate cancer is the second leading cause of cancer-related death among men in the United States, with the androgen receptor signaling playing a crucial role in the disease. Advances in high-throughput RNA sequencing techniques have identified a growing number of non-coding RNAs that are involved in prostate cancer progression.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Review Biophysics

DICER: structure, function, and regulation

Carlos A. Vergani-Junior et al.

Summary: Regulation of gene expression by small non-coding RNAs is crucial for eukaryotic cell function and survival. DICER, a type III ribonuclease, plays a key role in producing miRNAs and siRNAs, with additional functions in DNA repair and apoptosis. Dysregulation of DICER is linked to diseases and accelerated aging, highlighting its potential as a target for interventions to promote health and longevity.

BIOPHYSICAL REVIEWS (2021)

Add to Collection

Article Medicine, Research & Experimental

STK10 knockout inhibits cell migration and promotes cell proliferation via modulating the activity of ERM and p38 MAPK in prostate cancer cells

Lu Zhang et al.

Summary: This study found that STK10 plays crucial roles in prostate cancer by regulating cell proliferation and migration through modulating p38 MAPK signaling and ERM protein activation. The findings provide new insights into the pathogenesis of prostate cancer and could lead to potential therapeutic targets in the future.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

miRDB: an online database for prediction of functional microRNA targets

Yuhao Chen et al.

NUCLEIC ACIDS RESEARCH (2020)

Add to Collection

Article Oncology

LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway

Kai Fang et al.

CARCINOGENESIS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database

Hsi-Yuan Huang et al.

NUCLEIC ACIDS RESEARCH (2020)

Add to Collection

Article Medicine, Research & Experimental

lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143

Yanlan Yu et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer

Song Park et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Methylcrotonoyl-CoA Carboxylase 2 Promotes Proliferation, Migration and Invasion and Inhibits Apoptosis of Prostate Cancer Cells Through Regulating GLUD1-P38 MAPK Signaling Pathway

Jianwen He et al.

ONCOTARGETS AND THERAPY (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth

Jun Luo et al.

ONCOTARGETS AND THERAPY (2020)

Add to Collection

Article Medicine, Research & Experimental

N-Myc mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer

Adeline Berger et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Add to Collection

Article Endocrinology & Metabolism

Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process

Zhenjie Zhu et al.

PROSTATE (2019)

Add to Collection

Article Virology

Expression Profile and Function Analysis of Long Non-coding RNAs in the Infection of Coxsackievirus B3

Lei Tong et al.

VIROLOGICA SINICA (2019)

Add to Collection

Article Multidisciplinary Sciences

LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc

Jiayin Tang et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Review Medicine, General & Internal

The Diagnosis and Treatment of Prostate Cancer A Review

Mark S. Litwin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Add to Collection

Editorial Material Urology & Nephrology

Antagonizing AR: MYC affects transcription

Louise Stone

NATURE REVIEWS UROLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation

H. Zhou et al.

ONCOGENE (2017)

Add to Collection

Review Genetics & Heredity

Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA

Iain M. Dykes et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2017)

Add to Collection

Review Oncology

Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance

Daniel J. Crona et al.

CANCERS (2017)

Add to Collection

Article Genetics & Heredity

Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer

Haiyang Guo et al.

NATURE GENETICS (2016)

Add to Collection

Article Oncology

Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer

Xuechao Wan et al.

ONCOTARGET (2016)

Add to Collection

Article Biochemistry & Molecular Biology

FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity

Zhichao Mei et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Add to Collection

Article Cell Biology

LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer

Ali Zhang et al.

CELL REPORTS (2015)

Add to Collection

Article Multidisciplinary Sciences

A long noncoding RNA connects c-Myc to tumor metabolism

Chiu-Lien Hung et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Add to Collection

Review Cell Biology

Androgen receptor-mediated gene repression

Andreas Grosse et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)

Add to Collection

Article Biochemistry & Molecular Biology

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

Leonardo Salmena et al.

CELL (2011)

Add to Collection

Article Medicine, Research & Experimental

Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

Jian-Liang Chou et al.

LABORATORY INVESTIGATION (2010)

Add to Collection

Article Oncology

The androgen receptor negatively regulates the expression of c-Met: Implications for a novel mechanism of prostate cancer progression

Meletios Verras et al.

CANCER RESEARCH (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.